MedPath

The association of erythropoiesis-stimulating agent resistance index (ERI), serum fetuin-A with butyrylcholinesterase in hemodialysis patients

Not Applicable
Conditions
Chronic kidney disease with hemodialysis
Registration Number
JPRN-UMIN000028064
Lead Sponsor
Oyokyo Kidney Research Institute Aomori Hospital
Brief Summary

We demonstrated the independent relationship between BChE and serum fetuin-A in patients on HD.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
215
Inclusion Criteria

Not provided

Exclusion Criteria

patients with active infection, autoimmune disease, active hepatitis, liver cirrhosis, and obvious cancerous cachexia.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate the degree of correlationship between ERI,serum fetuin-A level and serum butyrylcholinesterase level
Secondary Outcome Measures
NameTimeMethod
To determine multiple liner regression equation of fetuin-A and ERI
© Copyright 2025. All Rights Reserved by MedPath